Terms: = Breast cancer AND USP6, TRE2, 9098, ENSG00000129204, TRE17, Tre-2, HRP1 AND Treatment
5 results:
1. Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study.
Martei YM; Mokokwe L; Ngwako N; Kebuang K; Setlhako DI; Gabaatlhole G; Baaitse B; Segadimo T; Shulman LN; Barg F; Gaolebale BE
BMJ Open; 2024 Jan; 14(1):e073867. PubMed ID: 38296302
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of non-genomic, clinical risk and survival results in endocrine-sensitive, HER-2 negative, lymph node negative breast cancer.
Baena Cañada JM; Gámez Casado S; Rodríguez Pérez L; Quílez Cutillas A; Cortés Carmona C; Rosado Varela P; Estalella Mendoza S; Ramírez Daffós P; Benítez Rodríguez E
Med Clin (Barc); 2018 Dec; 151(12):469-475. PubMed ID: 29501438
[TBL] [Abstract] [Full Text] [Related]
3. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.
Mauri G; Sconfienza LM; Pescatori LC; Fedeli MP; Alì M; Di Leo G; Sardanelli F
Eur Radiol; 2017 Aug; 27(8):3199-3210. PubMed ID: 28050693
[TBL] [Abstract] [Full Text] [Related]
4. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.
de Azambuja E; Holmes AP; Piccart-Gebhart M; Holmes E; Di Cosimo S; Swaby RF; Untch M; Jackisch C; Lang I; Smith I; Boyle F; Xu B; Barrios CH; Perez EA; Azim HA; Kim SB; Kuemmel S; Huang CS; Vuylsteke P; Hsieh RK; Gorbunova V; Eniu A; Dreosti L; Tavartkiladze N; Gelber RD; Eidtmann H; Baselga J
Lancet Oncol; 2014 Sep; 15(10):1137-46. PubMed ID: 25130998
[TBL] [Abstract] [Full Text] [Related]
5. Antisense oligonucleotides to the epidermal growth factor receptor.
Witters L; Kumar R; Mandal M; Bennett CF; Miraglia L; Lipton A
Breast Cancer Res Treat; 1999 Jan; 53(1):41-50. PubMed ID: 10206071
[TBL] [Abstract] [Full Text] [Related]
